AcrySof IQ Vivity®, the First of its kind presbyopia correcting IOL with X-WAVE™ Technology – X-EDoF AcrySof IQ Vivity® is the First of its kind presbyopia correcting IOL with X-WAVE™ wavefront shaping technology1,2. This cutting-edge technology provides patients with a continuous extended range of vision from distance to functional near (Fig.1), stretching and shifting the wavefront rather than splitting it2. X-WAVE™provides a smooth and clear EDOF channel without the low contrast sensitivity of a pinhole lens and the visual disturbances caused by loss of light typical of the diffractive lens3. By shaping the wavefront, Vivity® X-EDOF utilises almost all of the light2, thereby reducing the patient’s need for spectacles, increasing visual acuity in dim light, and leading to a remarkably lower rate of visual disturbances as compared with classic EDOF lenses4-8. During the APAC Vivity® User Meeting, held online in October 2021 by Alcon, key opinion leaders shared their experience with this novel IOL option recently introduced in the Asia-Pacific region. Twenty-twenty vision and N8 at 50 cm are the standard expectations after cataract surgery with implantation of a AcrySoft IQ Vivity® IOL, according to A/Prof Chandra Bala. In his personal experience, Vivity® shows optimal outcomes both in pristine and non-pristine eyes, with high levels of satisfaction even in his most demanding patients. He reported the case of a patient who is also his colleague, a medical retina specialist who presented with posterior subcapsular cataract, preoperatively -0.62D in the right eye and -1.38D in the left eye. She was completely against the idea of being implanted with trifocal IOLs due to the potential visual disturbances and agreed to implant Vivity® in the right eye. Outcomes were so good that she asked to have the same lens implanted in the left eye, aiming for a plano target. Excellent distance, intermediate and near vision were achieved, with 20/12 UCVA, N4 at 40 cm and N5 at 60 cm in both eyes at 6 months. This case inspired ten surgeons in his practice, who had never implanted a presbyopia correcting lens before, to use Vivity® for their patients (Fig.2). More difficult cases of non-pristine eyes were managed equally well. His patients with a mild glaucoma or a history of uveitis were in fact all very happy with the outcomes, achieving good distance, near and intermediate vision. Two other challenging cases, an 83-year old patient with dry AMD and a very large subfoveal drusen, and a 62-year old patient with previous hyperopic LASIK correction, both achieved optimal results, with respectively 20/30 distance and N8 near acuity at one month post op, and 20/20 and N10 OD, 20/25 and N8 OS. Real-world clinical experiences sharing from APAC Vivity® User Meeting Moderated By: Dr. Ronald Yeoh Dr. Abhay R. Vasavada AcrySof IQ Vivity®, for better or for worse Fig.1 - The defocus curve shows a continuum of vision from distance to functional near, with a plateau-like horizontal profile between 0.5D and -0.5D, resulting in extended focal range9 Defocus curve IOL Usage PersonalEyes Fig.2 - AcrySof IQ Vivity® is increasingly becoming a standard of choice for presbyopia correction - commented by A/Prof Chandra Bala *Data by A/Prof Chandra Bala from PersonalEyes’s IOL Usage A/Prof Chandra Bala, personalEYES, NSW, Australia “AcrySof IQ Vivity® IOL is also suitable for patients with non-pristine eyes and retinal conditions, with encouraging postoperative results”. • AcrySof IQ Vivity® shows optimal outcomes in pristine and non-pristine eyes • AcrySof IQ Vivity® leads to high levels of satisfaction even in the most demanding patients Key highlights from surgeons’ clinical sharing in the User Meeting:
RkJQdWJsaXNoZXIy Njk2NTg0